Back
Trevi Therapeutics, Inc. Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
40
TRVI
Trevi Therapeutics, Inc.
Last Price:
$10.69
Seasonality Move:
91.5%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing slight selling pressure.
Trevi Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.47 | Buy |
| 20-day SMA: | 11.1 | Sell |
| 50-day SMA: | 11.96 | Sell |
| 200-day SMA: | 8.78 | Buy |
| 8-day EMA: | 2.34 | Buy |
| 20-day EMA: | 1 | Buy |
| 50-day EMA: | 0.41 | Buy |
| 200-day EMA: | 0.1 | Buy |
Trevi Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.84 | Buy |
| Relative Strength Index (14 RSI): | 42.54 | Sell |
| Chaikin Money Flow: | -717503 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Trevi Therapeutics, Inc. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Trevi Therapeutics, Inc. Stock
Is Trevi Therapeutics, Inc. Stock a Buy?
-
Trevi Therapeutics, Inc. share price is 10.51 while TRVI 8-day simple moving average is 10.47, which is a Buy signal.
-
The stock price of TRVI is 10.51 while Trevi Therapeutics, Inc. 20-day SMA is 11.10, which makes it a Sell.
-
Trevi Therapeutics, Inc. 50-day simple moving average is 11.96 while TRVI share price is 10.51, making it a Sell technically.
-
TRVI stock price is 10.51 and Trevi Therapeutics, Inc. 200-day simple moving average is 8.78, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Sell
40
Trevi Therapeutics, Inc. (TRVI)
is a Sell
Is Trevi Therapeutics, Inc. a Buy or a Sell?
-
Trevi Therapeutics, Inc. stock is rated a SellThe current Trevi Therapeutics, Inc. [TRVI] share price is $10.51. The Score for TRVI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Trevi Therapeutics, Inc. Stock Info
Market Cap:
1.3B
Price in USD:
10.51
Share Volume:
1.9M
Trevi Therapeutics, Inc. 52-Week Range
52-Week High:
14.39
52-Week Low:
3.77
Sell
40
Trevi Therapeutics, Inc. (TRVI)
is a Sell
Trevi Therapeutics, Inc. Share Price Forecast
-
What is the Trevi Therapeutics, Inc. stock price today?The Trevi Therapeutics, Inc. stock price is 10.51 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics, Inc. is overvalued.
Is Trevi Therapeutics, Inc. Stock a Buy?
-
Trevi Therapeutics, Inc. share price is 10.51 while TRVI 8-day exponential moving average is 2.34, which is a Buy signal.
-
The stock price of TRVI is 10.51 while Trevi Therapeutics, Inc. 20-day EMA is 1.00, which makes it a Buy.
-
Trevi Therapeutics, Inc. 50-day exponential moving average is 0.41 while TRVI share price is 10.51, making it a Buy technically.
-
TRVI stock price is 10.51 and Trevi Therapeutics, Inc. 200-day simple moving average is 0.10, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics, Inc.
Is Trevi Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Trevi Therapeutics, Inc.
Should I short Trevi Therapeutics, Inc. stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 0.84, suggesting Trevi Therapeutics, Inc. is a Buy
-
Trevi Therapeutics, Inc. Relative Strength Index (RSI) is 42.54, which suggest Trevi Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Trevi Therapeutics, Inc. is ( - ), which suggest Trevi Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics, Inc. is ( - ), which suggest Trevi Therapeutics, Inc. is a Buy
* Trevi Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.